162 related articles for article (PubMed ID: 17552958)
1. The reliability of the frequency-volume chart in assessing lower urinary tract symptoms.
Yap TL; Cromwell DA; Brown C; Emberton M; van der Meulen J
BJU Int; 2007 Jul; 100(1):111-5. PubMed ID: 17552958
[TBL] [Abstract][Full Text] [Related]
2. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures.
Yap TL; Brown C; Cromwell DA; van der Meulen J; Emberton M
BJU Int; 2009 Oct; 104(8):1104-8. PubMed ID: 19485993
[TBL] [Abstract][Full Text] [Related]
3. The relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms.
Yap TL; Cromwell DA; Brown C; van der Meulen J; Emberton M
Eur Urol; 2007 Sep; 52(3):811-8. PubMed ID: 17276583
[TBL] [Abstract][Full Text] [Related]
4. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.
Liao CH; Chung SD; Kuo HC
Int J Clin Pract; 2011 May; 65(5):552-8. PubMed ID: 21489080
[TBL] [Abstract][Full Text] [Related]
6. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
Unsal A; Cimentepe E
Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment on: the relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms.
De Nunzio C
Eur Urol; 2007 Sep; 52(3):818. PubMed ID: 17276582
[No Abstract] [Full Text] [Related]
9. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
Güler C; Tüzel E; Doğantekin E; Kiziltepe G
Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
[TBL] [Abstract][Full Text] [Related]
10. The optimal duration of frequency-volume charts related to compliance and reliability.
van Haarst EP; Bosch JL
Neurourol Urodyn; 2014 Mar; 33(3):296-301. PubMed ID: 24166989
[TBL] [Abstract][Full Text] [Related]
11. Nocturia in patients with lower urinary tract symptoms: association with diurnal voiding patterns.
Ku JH; Lim DJ; Byun SS; Paick JS; Oh SJ
BJU Int; 2004 May; 93(7):1005-8. PubMed ID: 15142152
[TBL] [Abstract][Full Text] [Related]
12. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
13. alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction.
Paick JS; Ku JH; Shin JW; Yang JH; Kim SW
BJU Int; 2006 May; 97(5):1017-23. PubMed ID: 16643483
[TBL] [Abstract][Full Text] [Related]
14. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
15. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
[TBL] [Abstract][Full Text] [Related]
16. Core Lower Urinary Tract Symptom score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms.
Homma Y; Yoshida M; Yamanishi T; Gotoh M
Int J Urol; 2008 Sep; 15(9):816-20. PubMed ID: 18657204
[TBL] [Abstract][Full Text] [Related]
17. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of autonomic nervous system activity in men with lower urinary tract symptoms (LUTS): analysis of heart rate variability in men with LUTS.
Choi JB; Lee JG; Kim YS
Urology; 2010 Jan; 75(1):138-42. PubMed ID: 19854482
[TBL] [Abstract][Full Text] [Related]
19. Frequency volume charts in the assessment and evaluation of treatment: how should we use them?
Bryan NP; Chapple CR
Eur Urol; 2004 Nov; 46(5):636-40. PubMed ID: 15474275
[TBL] [Abstract][Full Text] [Related]
20. The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women.
Jimenez-Cidre MA; Lopez-Fando L; Esteban-Fuertes M; Prieto-Chaparro L; Llorens-Martinez FJ; Salinas-Casado J; Castro-Diaz D; Müller-Arteaga C; Adot-Zurbano JM; Rodriguez-Escobar F; Gutierrez C; Arlandis-Guzman S; Bonillo-Garcia MA; Madurga-Patuel B; Leva-Vallejo M; Franco de Castro A; Peri-Cusi L; Conejero-Sugrañes J; Jimenez-Calvo J; Rebollo P; Mora A
Neurourol Urodyn; 2015 Feb; 34(2):128-32. PubMed ID: 24264859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
